Publications

Filter
Editorial
2014

Editors' report, November 2013

Somogyi, A. A., Lewis, L. D., Cohen, A. F., Flockhart, D. A., Ferro, A., Loke, Y. K. & Ritter, J. M., Mar 1 2014, In : British Journal of Clinical Pharmacology. 77, 3, p. 401-402 2 p.

Research output: Contribution to journalEditorial

2013

Amlodipine - Not a significant contributor to clopidogrel non-response?

Kreutz, R. P. & Flockhart, D. A., Apr 1 2013, In : Heart. 99, 7, p. 437-439 3 p.

Research output: Contribution to journalEditorial

2 Scopus citations
2012

Breast cancer pharmacogenomics: Where we are going

Newman, W. G. & Flockhart, D., Apr 1 2012, In : Pharmacogenomics. 13, 6, p. 629-631 3 p.

Research output: Contribution to journalEditorial

2 Scopus citations
2008

A model citizen? Is tamoxifen more effective than aromatase inhibitors if we pick the right patients?

Hayes, D. F., Stearns, V., Rae, J. & Flockhart, D., May 1 2008, In : Journal of the National Cancer Institute. 100, 9, p. 610-613 4 p.

Research output: Contribution to journalEditorial

37 Scopus citations
2007

Flash points

Carpenter, J. S. & Flockhart, D., Dec 10 2007, In : Journal of Clinical Oncology. 25, 35, p. 5546-5547 2 p.

Research output: Contribution to journalEditorial

Germline pharmacogenetics of tamoxifen response: Have we learned enough?

Desta, Z. & Flockhart, D. A., Nov 20 2007, In : Journal of Clinical Oncology. 25, 33, p. 5147-5149 3 p.

Research output: Contribution to journalEditorial

24 Scopus citations
1996

Drug interactions, cardiac toxicity, and terfenadine: From bench to clinic?

Flockhart, D. A., Apr 26 1996, In : Journal of Clinical Psychopharmacology. 16, 2, p. 101-103 3 p.

Research output: Contribution to journalEditorial

33 Scopus citations